| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8526336 | Biomedicine & Pharmacotherapy | 2018 | 9 Pages | 
Abstract
												In addition to previously studied DPPIV inhibitor, PTY-2 also acts as incretin receptors agonist and protects against STZ-induced diabetes by down regulating β cells apoptosis.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Shivani Srivastava, Priya Shree, Harsh Pandey, Yamini Bhusan Tripathi, 
											